Cargando…

Acute respiratory distress syndrome following administration of gadolinium contrast agent: a case report

BACKGROUND: Gadolinium-based contrast agents are used extensively in magnetic resonance imaging to assist diagnosis of medical conditions. Despite their documented safety profile, severe adverse events do occur, and their documentation may serve to raise the awareness of the medical community. CASE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Osawa, Eduardo Atsushi, Kleiman, Juliana Fernandez Fernandes, Maciel, Alexandre Toledo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668706/ https://www.ncbi.nlm.nih.gov/pubmed/36384694 http://dx.doi.org/10.1186/s13256-022-03643-w

Ejemplares similares

Acute respiratory distress syndrome after the use of gadolinium contrast agent
por: Kerget, Bugra, et al.
Publicado: (2018)

Late-onset acute respiratory distress syndrome induced by a gadolinium-based contrast agent
por: Kato, Kazuhiko, et al.
Publicado: (2019)

Acute Respiratory Distress Syndrome after the Use of Gadolinium Contrast Media
por: Park, Jihye, et al.
Publicado: (2015)

Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration
por: Davies, Julie, et al.
Publicado: (2022)

Gadolinium deposition in the brain of dogs after multiple intravenous administrations of linear gadolinium based contrast agents
por: Richter, Henning, et al.
Publicado: (2020)

Gadolinium retention within multiple rat organs after intra-articular administration of gadolinium-based contrast agents
por: Ringler, Michael D., et al.
Publicado: (2021)

Gadolinium Retention in the Brain of Mother and Pup Mouse: Effect of Pregnancy and Repeated Administration of Gadolinium‐Based Contrast Agents
por: Yao, Xiang, et al.
Publicado: (2022)

Gadolinium contrast agents: Over exposure?
por: Biederman, Robert W, et al.
Publicado: (2016)

T(1) Shortening in the Cerebral Cortex after Multiple Administrations of Gadolinium-based Contrast Agents
por: Khant, Zaw Aung, et al.
Publicado: (2016)

Gadolinium retention and clearance after administration of macrocyclic magnetic resonance contrast agents to rats
por: Bussi, Simona, et al.
Publicado: (2019)

Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents
por: Lohrke, Jessica, et al.
Publicado: (2017)

Gadolinium-DTPA: A New Contrast Agent
por: Niendorf, H. P.
Publicado: (1988)

Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents: Comparative Study in Rats
por: Frenzel, Thomas, et al.
Publicado: (2017)

Impact of brain tumors and radiotherapy on the presence of gadolinium in the brain after repeated administration of gadolinium-based contrast agents: an experimental study in rats
por: Jost, Gregor, et al.
Publicado: (2019)

Changes in Urinary and Serum Levels of Novel Biomarkers after Administration of Gadolinium-based Contrast Agents
por: Mawad, Habib, et al.
Publicado: (2016)

Characteristics and Risk Factors for Mortality in Critically Ill Patients with COVID-19 Receiving Invasive Mechanical Ventilation: The Experience of a Private Network in Sao Paulo, Brazil
por: Osawa, Eduardo Atsushi, et al.
Publicado: (2022)

Concurrent hospitalization of a married couple presenting with distinct symptoms but diagnosed with a life-threatening infectious disease
por: Osawa, Eduardo Atsushi, et al.
Publicado: (2022)

An algorithm to predict the need for invasive mechanical ventilation in hospitalized COVID-19 patients: the experience in Sao Paulo
por: Osawa, Eduardo Atsushi, et al.
Publicado: (2022)

Linear Gadolinium-Based Contrast Agents Are Associated With Brain Gadolinium Retention in Healthy Rats
por: Robert, Philippe, et al.
Publicado: (2016)

Gadolinium Complexes as Contrast Agent for Cellular NMR Spectroscopy
por: Sakol, Nat, et al.
Publicado: (2020)

Does serial administration of gadolinium‐based contrast agents affect patient neurological and neuropsychological status? Fourteen‐year follow‐up of patients receiving more than fifty contrast administrations
por: Vymazal, Josef, et al.
Publicado: (2019)

A rare case of acute respiratory distress syndrome caused by use of gadolinium‐based magnetic resonance imaging contrast media
por: Lee, Yi, et al.
Publicado: (2019)

Biocompatible Polyhydroxyethylaspartamide-based Micelles with Gadolinium for MRI Contrast Agents
por: Jeong, Sang Young, et al.
Publicado: (2010)

Immediate reaction to gadolinium based contrast agent with fatal outcome()()()
por: Behzadi, Ashkan Heshmatzadeh, et al.
Publicado: (2018)

Gadolinium-Based Contrast Agents Hypersensitivity: A Case Series
por: Nucera, Eleonora, et al.
Publicado: (2021)

Gadolinium-based contrast agents in neurofibromatosis type 1 (Review)
por: Năstase, Florentina, et al.
Publicado: (2021)

Recent Advances in Gadolinium Based Contrast Agents for Bioimaging Applications
por: Fatima, Atiya, et al.
Publicado: (2021)

Signal Intensity of the Cerebrospinal Fluid after Intravenous Administration of Gadolinium-based Contrast Agents: Strong Contrast Enhancement around the Vein of Labbe
por: Ohashi, Toshio, et al.
Publicado: (2018)

Visible T1-hyperintensity of the dentate nucleus after multiple administrations of macrocyclic gadolinium-based contrast agents: yes or no?
por: Splendiani, Alessandra, et al.
Publicado: (2019)

Magnetic resonance imaging of endolymphatic hydrops: a comparison of methods with and without gadolinium-based contrast agent administration
por: Ohashi, Toshio, et al.
Publicado: (2023)

The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review
por: Olchowy, Cyprian, et al.
Publicado: (2017)

Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T(1) contrast
por: Ananta, Jeyarama S., et al.
Publicado: (2010)

Confirmation of Age-dependence in the Leakage of Contrast Medium around the Cortical Veins into Cerebrospinal Fluid after Intravenous Administration of Gadolinium-based Contrast Agent
por: Naganawa, Shinji, et al.
Publicado: (2020)

The effect of gadolinium-based contrast agent administration on magnetic resonance fingerprinting-based T(1) relaxometry in patients with prostate cancer
por: Sushentsev, Nikita, et al.
Publicado: (2020)

Thermal Excitation of Gadolinium-Based Contrast Agents Using Spin Resonance
por: Dinger, Steven C., et al.
Publicado: (2016)

The New Restrictions on the Use of Linear Gadolinium-based Contrast Agents in Japan
por: Kanda, Tomonori
Publicado: (2018)

Effect of different doses of gadolinium contrast agent on clinical outcomes in MS
por: Ackermans, Nathalie, et al.
Publicado: (2019)

Investigating the Impact of Gadolinium-Based Contrast Agents on the Corrected QT Interval
por: Gress, Kyle L, et al.
Publicado: (2020)

PEG-modified gadolinium nanoparticles as contrast agents for in vivo micro-CT
por: Cruje, Charmainne, et al.
Publicado: (2021)

Formation of gadolinium–ferritin from clinical magnetic resonance contrast agents
por: Neburkova, Jitka, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_csue89c9anevhecet6oq17lkju